Quantitative evaluation of vitamin E in the treatment of angina pectoris

American Heart Journal

Volumn 93, Issue 4, 1977, Pages 444-449

  Gillilan, Ronald E ^a   Mondell, Brian ^a   Warbasse, J Richard ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; PLACEBO;

ANGINA PECTORIS; DRUG EFFICACY; DRUG THERAPY; SYSTOLIC TIME INTERVAL; THERAPY;

ANGINA PECTORIS; CLINICAL TRIALS; EXERTION; HEART FUNCTION TESTS; HUMAN; MIDDLE AGE; MYOCARDIAL CONTRACTION; PATIENT COMPLIANCE; VITAMIN E;

EID: 0017333155     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/S0002-8703(77)80406-7     Document Type: Article

References (28)

1. Critical appraisal of the therapeutic value of alpha-tocophero
2. Effect of vitamin E in coronary heart disease
3. Vitamin E in heart disease
4. Twenty-four years using alpha-tocopherol in degenerative cardiovascular disease
5. Effects of vitamin E: Good and bad
6. Vitamin E in angina pectoris
7. Failure of alpha-tocopherol to influence chest pain in patients with heart disease
8. Vitamin E in three treatment of angina pectoris
9. Vitamin E in angina pectoris
10. The effect of tocopherol and of fat on the resistance of rats to anoxic anoxia
11. Tocopherol prophylaxis in multiple exposures to hypoxia
12. In vitro effect of alpha-tocopherol phosphate on oxygen consumption of muscle from vitamin E-deficient animals
13. On certain effects of alpha-tocopheryl phosphate on oxidative mechanisms of striated muscle
14. La accion de la vitamin E en el infarto de miocardia estudio experimental
15. On the antithrombin and antiproteolytic activity of alpha tocopherol phosphate
16. Studies on a antithrombin
17. The influence of vitamin E on vascular disease
18. The use of alpha-tocopherol in acute and subacute thrombophlebitis
19. Alpha-tocopherol in the treatment of intermittent claudication
20. On tailoring the dose of alpha tocopherol for cardiac patients
21. Identification of alpha-tocopherol from tissues by combined gas-liquid chromatography, mass spectometry and infrared spectoscopy
22. Systolic time intervals in cardiac disease
23. Maximal exercise testing in assessing cardiovascular function
24. Maximal oxygen intake and nomographic assessment of functional aerobic impariment in cardiovascular disease
25. Exercise tolerance in patients with angina pectoris
26. Changes in maximal exercise performance in the evaluation of saphenous vein bypass surgery
27. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris
28. The medical treatment of angina pectoris. II. Design of an antianginal drug study